ID
26667
Beschrijving
Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab; ODM derived from: https://clinicaltrials.gov/show/NCT00875238
Link
https://clinicaltrials.gov/show/NCT00875238
Trefwoorden
Versies (2)
- 23-10-17 23-10-17 -
- 20-09-21 20-09-21 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
23 oktober 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00875238
Eligibility Breast Cancer NCT00875238
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00875238
- StudyEvent: Eligibility
C1552534 (UMLS CUI [1,2])
C0750729 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0205539 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,3])
C0205370 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])
C0024485 (UMLS CUI [2])
C2735362 (UMLS CUI [2,1])
C0013850 (UMLS CUI [2,2])
C0009199 (UMLS CUI [3])
C3693688 (UMLS CUI [4])
C0522670 (UMLS CUI [5])
C0038917 (UMLS CUI [6,1])
C0524850 (UMLS CUI [6,2])
C0559546 (UMLS CUI [2,1])
C3249258 (UMLS CUI [2,2])
C0587053 (UMLS CUI [2])
C0030705 (UMLS CUI [3,1])
C1548787 (UMLS CUI [3,2])
C0024485 (UMLS CUI [3,3])
C1710020 (UMLS CUI [3,4])
C0282564 (UMLS CUI [2])